CTD-ILD Comprehensive e-Learning
A comprehensive overview of ARD-ILDs with a focus on early detection and optimal management to offer your patients the best care
*ARD-ILD: This term can be substituted with CTD-ILD
A comprehensive overview of ARD-ILDs with a focus on early detection and optimal management to offer your patients the best care
We are excited to share our e-learning series on autoimmune rheumatic disease associated with interstitial lung disease (ARD-ILD), specifically developed for pulmonologists and rheumatologists. This comprehensive series aims to increase your awareness of ARD-ILDs and provide you with the knowledge to enhance patient outcomes. The series covers the following topics:
Understanding clinical approaches to screen, diagnose, and monitor ARD-ILDs
Background, epidemiology, pathogenesis, and risk factors of ARD-ILDs
Insights into screening methods and key diagnostic indicators for ARD in ILD
Management recommendations for ARD-ILDs and guidelines on when to start antifibrotic treatment
During the e-learning modules, you will benefit from insightful conversations between pulmonologist Prof. Dr. Elisabeth Bendstrup (Aarhus University Hospital, Denmark) and rheumatologist Prof. Dr. Vanessa Smith (University of Ghent, Belgium). Each module is designed for your convenience and can be completed in just 15-25 minutes!
Access each module by clicking the link below.
Module 1: Epidemiology, Pathogenesis, Risk Factors
After completing Module 1, you will:
Understand what ARD-ILDs encompass
Have an overview of the epidemiology of ILD in ARD
Gain a basic understanding of the pathogenesis of ARD-ILD
Know the important risk factors for ILD in ARD
Module 2: Clinical presentation, Role of Screening
After completing Module 2, you will:
Gain insights into screening methods for ILD in ARDs
Know what to look for when diagnosing ARD in ILDs
Be aware of signs and symptoms that raise suspicion for ILD
Module 3: Diagnostic Tests, ILD Monitoring, Recognizing Early Signs of Progression
After completing Module 3, you will:
Be familiar with relevant tests to diagnose ILD
Know how to monitor for progression
Be able to recognize progressive fibrosis in ARD-ILD
Module 4: Treatment of ARD-ILD
After completing Module 4, you will:
Be familiar with recommendations to manage ARD-ILDs
Gain insights into when to start antifibrotic treatment with nintedanib
Review a final summary of the four modules and complete a quiz to test your knowledge